Kimberly-Clark Corporation
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Kimberly-Clark Corporation (KMB). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| North America | – | – | $10.47B 51.9% | $11.00B 64.9% · +5.0% | $11.02B 65.7% · +0.2% | $10.75B 65.4% · -2.4% |
| International Personal Care (IPC) | – | – | $6.05B 30.0% | $5.94B 35.1% · -1.9% | $5.74B 34.3% · -3.3% | $5.69B 34.6% · -0.9% |
| Personal Care | $9.34B 48.8% | $10.27B 52.8% · +9.9% | – | – | – | – |
| Consumer Tissue | $6.72B 35.1% | $6.03B 31.0% · -10.2% | – | – | – | – |
| K-C Professional and Other | $3.02B 15.8% | $3.07B 15.8% · +1.8% | – | – | – | – |
| Corporate and Other | $64.0M 0.3% | $67.0M 0.3% · +4.7% | – | – | – | – |
| International Family Care and Professional (IFP) | – | – | $3.65B 18.1% | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| North America | – | – | $2.11B 20.2% | $2.51B 22.9% | $2.54B 23.1% | $2.55B 23.7% |
| International Personal Care (IPC) | – | – | $670.0M 11.1% | $673.0M 11.3% | $826.0M 14.4% | $796.0M 14.0% |
| Personal Care | $1.93B 20.7% | $1.86B 18.1% | – | – | – | – |
| Consumer Tissue | $1.45B 21.6% | $888.0M 14.7% | – | – | – | – |
| K-C Professional and Other | $528.0M 17.5% | $404.0M 13.2% | – | – | – | – |
| Corporate and Other | -$719.0M -1,123.4% | -$559.0M -834.3% | – | – | – | – |
| International Family Care and Professional (IFP) | – | – | $256.0M 7.0% | – | – | – |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by product line
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Baby and Child Care Products | $6.40B 33.5% | $7.20B 37.1% · +12.5% | $7.17B 35.5% · -0.5% | $7.05B 41.1% · -1.6% | $7.06B 42.0% · +0.0% | $6.77B 41.2% · -4.0% |
| Family Care | – | – | – | $4.02B 23.5% | $3.93B 23.4% · -2.4% | $4.06B 24.7% · +3.3% |
| Adult Care | – | – | $1.73B 8.6% | $1.81B 10.6% · +4.6% | $1.86B 11.1% · +3.0% | $1.95B 11.8% · +4.5% |
| Professional | – | – | – | $2.39B 13.9% | $2.15B 12.8% · -9.8% | $1.84B 11.2% · -14.5% |
| Feminine Care | – | – | $1.70B 8.4% | $1.79B 10.4% · +5.4% | $1.72B 10.2% · -3.7% | $1.71B 10.4% · -0.9% |
| All Other | $3.00B 15.7% | $3.10B 16.0% · +3.3% | $85.0M 0.4% · -97.3% | $87.0M 0.5% · +2.4% | $84.0M 0.5% · -3.4% | $124.0M 0.8% · +47.6% |
| Consumer Tissue Products | $6.70B 35.1% | $6.00B 30.9% · -10.4% | $6.24B 30.9% · +4.1% | – | – | – |
| Away from Home Professional Products | $3.00B 15.7% | $3.10B 16.0% · +3.3% | $3.26B 16.1% · +5.0% | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.